Literature DB >> 1465208

In vivo binding of [11C]Ro15-4513 in human brain measured with PET.

O Inoue1, T Suhara, T Itoh, K Kobayashi, K Suzuki, Y Tateno.   

Abstract

Ro15-4513, an azide derivative of benzodiazepine antagonist flumazenil (Ro15-1788), and Ro15-1788 were labelled with carbon 11. Sequential PET scans following injection of [11C]Ro15-4513 or [11C]Ro15-1788 into normal male healthy volunteers were measured, and kinetic analysis using pons as a reference region was performed. [11C]Ro15-4513 was highly accumulated in frontal cortex, temporal cortex, hippocampus and relatively lower accumulation in occipital cortex, whereas almost homogeneous distribution of Ro15-1788 throughout cortex area was seen. The kinetic analysis revealed that such differences of regional distribution in brain between two labelled ligands were mainly due to the regional difference of the dissociation rate constants in vivo (k4). [11C]Ro15-4513 may be a useful tool for the in vivo study of benzodiazepine receptors in human brain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465208     DOI: 10.1016/0304-3940(92)90004-q

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513.

Authors:  Luanda J Pym; Susan M Cook; Thomas Rosahl; Ruth M McKernan; John R Atack
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 2.  Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.

Authors:  Victor W Pike
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

3.  Quantification of [11C]Ro15-4513 GABAAα5 specific binding and regional selectivity in humans.

Authors:  Jim Fm Myers; Robert A Comley; Roger N Gunn
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

4.  Test-retest reproducibility of quantitative binding measures of [11C]Ro15-4513, a PET ligand for GABAA receptors containing alpha5 subunits.

Authors:  Colm J McGinnity; Daniela A Riaño Barros; Lula Rosso; Mattia Veronese; Gaia Rizzo; Alessandra Bertoldo; Rainer Hinz; Federico E Turkheimer; Matthias J Koepp; Alexander Hammers
Journal:  Neuroimage       Date:  2017-03-11       Impact factor: 6.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.